课题基金 / 基金详情

项目摘要

项目成果

Petr Kalab的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In 2011-2012 we developed orthogonal chemiluminescence screen to identify aspecifically acting inhibitors. We also designed and tested cell-based assays to monitor the effects of the inhibitors on the RanGTP and importin alpha1/importin beta-regulated nuclear import and mitotic spindle assembly. We tested those secondary screens with a group of 20 primary screen hits. Although we identified at least one validated primary screen hit that displayed activity also in the secondary screens, we are now collaborating with NCATS (formerly NCGC) to optimize the secondary screens for automated secondary screens with the entire set of 1000 candidate inhibitors. Our objective is to identify specifically acting inhibitory compounds which display the expected biological activity. This data is required to secure R03 funding for the second year of the project where we will focus on the best identified inhibitor(s) and analyze their mechanism of action and optimize their performance based on structure-activity relationship analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAN-REGULATED IMPORTIN BETA CARGOS
  • 批准号:
    8171445
  • 项目类别:
  • 资助金额:
    $0.08万
  • 财政年份:
    2010
  • 负责人:
    Petr Kalab
  • 依托单位:
Cellular functions of Ran GTPase
Cellular functions of Ran GTPase
Cellular functions of Ran GTPase
海外基金